Back
NeuroMetrix Vs. Perspective Therapeutics Industry Stock Comparison
Sell
38
NURO
NeuroMetrix
Last Price:
4.00
Seasonality Move:
-6.53%
Sell
30
CATX
Perspective Therapeutics
Last Price:
12.54
Seasonality Move:
-10.27%
Sell
38
NeuroMetrix (NURO)
is a Sell
Is NeuroMetrix a Buy, Sell or Hold?
- The current NeuroMetrix [NURO] share price is $3.93. The Score for NURO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- NURO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $12.57. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NURO Stock Price Chart
What is NeuroMetrix's stock price today?
-
The NeuroMetrix share price today is $3.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NURO is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $12.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.
NURO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 53.15 | Buy |
Chaikin Money Flow: | -6770 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.77 - 4.01) | Buy |
Bollinger Bands (100): | (3.46 - 4.06) | Buy |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 39.77 | Sell |
Chaikin Money Flow: | -64266 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.01 - 15.73) | Sell |
Bollinger Bands (100): | (11.41 - 15.47) | Sell |
NURO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.93 | Sell |
20-day SMA: | 3.92 | Buy |
50-day SMA: | 3.66 | Buy |
200-day SMA: | 3.7 | Buy |
8-day EMA: | 3.96 | Sell |
20-day EMA: | 3.89 | Buy |
50-day EMA: | 3.78 | Buy |
200-day EMA: | 4.34 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.69 | Sell |
20-day SMA: | 14.08 | Sell |
50-day SMA: | 13.75 | Sell |
200-day SMA: | 11.57 | Buy |
8-day EMA: | 12.79 | Sell |
20-day EMA: | 13.53 | Sell |
50-day EMA: | 13.63 | Sell |
200-day EMA: | 11.56 | Buy |
NeuroMetrix Earnings Growth & NURO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
NeuroMetrix Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |